ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

©Martial Red/Shutterstock.com

The ICD-10 transition will continue into the next year for practices. Here are some tips you’ll need to take in 2016.

©Pressmaster/Shutterstock.com

With a dearth of coders thanks to the ICD-10 transition, some practices find that training current staff is the best way to get good coders.

Health care reform, the patient-centered medical home, and the impact of environmental change on global health are just a few of the topics to be discussed at the Internal Medicine 2009 Medicine 2009 in Philadelphia this week.

With the help of a scalp-cooling device, 50% of women with breast cancer undergoing neoadjuvant or adjuvant chemotherapy were able to prevent hair loss, according to the results of the SCALP trial.

Postmenopausal women with breast cancer who took aromatase inhibitors (AI) had endothelial dysfunction, according to the results of a study.

©puresolutions/Shutterstock.com

Find the tech solutions that are correct for your practice's patients and don't get lured by the fanciest gadgets and apps, say experts.

In a potential step toward precision endocrine therapy, a new study found that certain single nucleotide polymorphisms within CSMD1 are associated with changes in estrogen levels in postmenopausal breast cancer patients.

©sibgat/Shutterstock.com

A new report reveals that life expectancy is on the decline thanks to rising fatalities from heart disease and other serious conditions.

Circulating tumor DNA (ctDNA) measured by liquid biopsy was able to identify actionable mutations and provide a real-time molecular assessment of metastatic breast cancer, according to a new study.

FDA changed Flulaval's indication from age ≥3 years to age ≥6 months. The advantage? Now one size, 0.5 cc, fits all.

A 43-year-old woman presents with vaginal bleeding, and endocervical biopsy is performed. What is you diagnosis?

"My child won't be intimate before marriage," is a common parental refrain. The CDC says, don't bet on it. Do you know the odds?

This interview examines a study that looked at the health-related quality of life of multiple myeloma patients in a real-world setting who underwent maintenance therapy after autologous stem cell transplant.

This interview examines treatment-related cardiotoxicity and the risk of second malignancy in patients with Hodgkin lymphoma.

©MiTi/Shutterstock.com

Recent research indicates that PAs are an effective resource for hospitals to improve outcomes at a lower cost of care.

Letting people know what a great radiologist you are.

This interview examines the role of functional imaging to direct therapy (escalation or de-escalation) for early and advanced Hodgkin lymphoma.

Adding the PARP inhibitor veliparib to carboplatin and paclitaxel chemotherapy significantly increased response rates among women with BRCA1 or BRCA2 mutations and locally recurrent or metastatic breast cancer, according to a randomized phase II trial.

In this video we discuss longer term results of the phase III SABRINA study, which tested the safety and efficacy of subcutaneous rituximab in patients with follicular lymphoma.

Primary care drugs were approved in nearly every month of 2016. This top-line slide show highlights 20 you should know about.

Pages

Subscribe to No name on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.